A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.

Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors

NCT05153096 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors

NCT06158477 ·Status: RECRUITING ·Phase: PHASE1

A Phase I Study of RGT-264 in Subjects With Advanced Solid Tumors

NCT05764915 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

NCT04866485 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

NCT07042100 ·Status: RECRUITING ·Phase: PHASE1

A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors

NCT07050459 ·Status: RECRUITING ·Phase: PHASE1

A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors

NCT07077434 ·Status: RECRUITING ·Phase: PHASE1

Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients

NCT06212076 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors

NCT07038005 ·Status: RECRUITING ·Phase: PHASE1

Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China

NCT01863485 ·Status: COMPLETED ·Phase: PHASE1

A Study of TQB3455 Tablets in Subjects With Advanced Malignancies

NCT04340427 ·Status: UNKNOWN ·Phase: PHASE1

TT-00973-MS Tablets in Patients With Advanced Solid Tumors

NCT05673538 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study of HMPL-295S1 in Patients With Advanced Malignant Solid Tumors

NCT04908046 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial Carcinoma

NCT04871334 ·Status: UNKNOWN ·Phase: PHASE1

STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS

NCT04635631 ·Status: COMPLETED ·Phase: PHASE1

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.

NCT06600022 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment

NCT06987500 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

SB17170 Phase 1 Clinical Trial in Solid Tumors

NCT05522868 ·Status: RECRUITING ·Phase: PHASE1

SG2918 For Advanced Malignant Tumors

NCT06167486 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

NCT01610479 ·Status: COMPLETED ·Phase: PHASE1

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

NCT06386146 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors

NCT03844438 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors

NCT06390774 ·Status: RECRUITING ·Phase: PHASE1

Clinical Trial of TQB3002 in Patients With Advanced Cancers

NCT06662760 ·Status: RECRUITING ·Phase: PHASE1

Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy

NCT03121846 ·Status: UNKNOWN ·Phase: PHASE2